ConductScience.org, home

Paper5654091

Fate of chromosome-marked mouse bone marrow cells tranfused into normal syngeneic recipients.

Micklem HS and 3 others. Transplantation, 1968. Cited by 116 papers, by iCite.

Cite this record

ConductScience Library. Fate of chromosome-marked mouse bone marrow cells tranfused into normal syngeneic recipients. Papers, record 5654091. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/5654091

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Fate of chromosome-marked mouse bone marrow cells tranfused into normal syngeneic recipients.
PubMed
Journal
Transplantation
PubMed
Year
1968
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
116
iCite
Revised in PubMed
2013-11-21
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Micklem HSH S
2Clarke CMC M
3Evans EPE P
4Ford CEC E

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Bone MarrowMajor topic
Bone Marrow CellsMajor topic
HematopoiesisMajor topic
Animals
Colchicine
Injections, Intraperitoneal
Injections, Intravenous
Lymph Nodes
Male
Mice
Mitosis
Spleen
Thymus Gland

Source PubMed

Download CSV of topics

Cited by34

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 116 citations.

PMIDTitleJournalYearIn PapersSource
37460391Mobilization-based engraftment of haematopoietic stem cells: a new perspective for chemotherapy-free gene therapy and transplantation.Br Med Bull2023https://conductscience.org/library/papers/37460391PubMed
32206674Generation of bone marrow chimeras using X-ray irradiation: comparison to cesium irradiation and use in immunotherapy.J Biol Methods2020https://conductscience.org/library/papers/32206674PubMed
30664721Targeting the niche: depleting haemopoietic stem cells with targeted therapy.Bone Marrow Transplant2019https://conductscience.org/library/papers/30664721PubMed
24550108Cell competition: how to eliminate your neighbours.Development2014https://conductscience.org/library/papers/24550108PubMed
22312367Nonengraftment haploidentical cellular therapy for hematologic malignancies.Adv Hematol2012https://conductscience.org/library/papers/22312367PubMed
21999373Hematopoietic stem cell expansion and gene therapy.Cytotherapy2011https://conductscience.org/library/papers/21999373PubMed
21236391Purified hematopoietic stem cell transplantation: the next generation of blood and immune replacement.Hematol Oncol Clin North Am2011https://conductscience.org/library/papers/21236391PubMed
20493393Purified hematopoietic stem cell transplantation: the next generation of blood and immune replacement.Immunol Allergy Clin North Am2010https://conductscience.org/library/papers/20493393PubMed
19258595Conditional deletion of STAT5 in adult mouse hematopoietic stem cells causes loss of quiescence and permits efficient nonablative stem cell replacement.Blood2009https://conductscience.org/library/papers/19258595PubMed
18651698Space-time considerations for hematopoietic stem cell transplantation.Eur J Immunol2008https://conductscience.org/library/papers/18651698PubMed
18033883Efficient transplantation via antibody-based clearance of hematopoietic stem cell niches.Science2007https://conductscience.org/library/papers/18033883PubMed
16638929Simultaneous bone marrow and intestine transplantation promotes marrow-derived hematopoietic stem cell engraftment and chimerism.Blood2006https://conductscience.org/library/papers/16638929PubMed
16459181Busulfan pharmacokinetics, toxicity, and low-dose conditioning for autologous transplantation of genetically modified hematopoietic stem cells in the rhesus macaque model.Exp Hematol2006https://conductscience.org/library/papers/16459181PubMed
16439683Mobilization as a preparative regimen for hematopoietic stem cell transplantation.Blood2006https://conductscience.org/library/papers/16439683PubMed
15776575Contribution of a thymic humoral factor to the development of an immunologically competent population from cells of mouse bone marrow.J Exp Med1971https://conductscience.org/library/papers/15776575PubMed
15291347Low dose total body irradiation followed by allogeneic lymphocyte infusion for refractory hematologic malignancy--an updated review.Leuk Lymphoma2004https://conductscience.org/library/papers/15291347PubMed
15218097Donor-specific transplantation tolerance: the paradoxical behavior of CD4+CD25+ T cells.Proc Natl Acad Sci U S A2004https://conductscience.org/library/papers/15218097PubMed
14749701Murine marrow cellularity and the concept of stem cell competition: geographic and quantitative determinants in stem cell biology.Leukemia2004https://conductscience.org/library/papers/14749701PubMed
12931234The marrow stem cell: the continuum.Bone Marrow Transplant2003https://conductscience.org/library/papers/12931234PubMed
11994419Hematopoietic stem cells are uniquely selective in their migratory response to chemokines.J Exp Med2002https://conductscience.org/library/papers/11994419PubMed

See all 34 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/5654091

GET https://conductscience.org/api/papers/v1/5654091/cited_by?page=2